verified SJR 0,672 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 99. It has a price of 2395 €. It has an SJR impact factor of 0,672 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,672.

Expert Opinion on Pharmacotherapy focuses its scope in these topics and keywords: treatment, management, cancer, therapeutic, update, inhibitors, pharmacological, challenges, failure, disordersnew, ...

ISSN: 1465-6566

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,672 Q2

H-index 99

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,672

H-index

Docs (year)

209

Docs 3y

644

Total refs

17649

Cites 3y

1443

Citable 3y

553

Cites/Doc 2y

2.21

Ref/Doc

84.44

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis

Vascular restenosis -striving for therapy

Colesevelam HCl: a non-systemic lipid-altering drug

Clinical-economic appropriateness of drug treatments: designing a method that combines evidence-based information and cost assessments to construct league tables accounting for the potential number of patients

Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia

Chemotherapy for major food-borne trematodes: a review

Caspofungin: first approved agent in a new class of antifungals

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

Brinzolamide plus brimonidine for the treatment of glaucoma: an update

Brinzolamide

Brimonidine tartrate for the treatment of glaucoma

Botanical medicine and cancer: a review of the safety and efficacy

SHOW MORE ARTICLES

Bedaquiline and delamanid in tuberculosis

A cost-benefit analysis of chemotherapy for gastric cancer

Bacterial meningitis: a review of effective pharmacotherapy

Babesiosis in humans: a treatment review

Available pharmacological treatments for anorexia nervosa

Assessing the efficacy of medical treatments for alcohol use disorders

Antagonist molecules in the treatment of angina

An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension

Aggrenox' versus other pharmacotherapy in preventing recurrent stroke

Adefovir dipivoxil in chronic hepatitis B infection

Acute promyelocytic leukaemia: a review

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

FAQs

Expert Opinion on Pharmacotherapy has an SJR of 0,672 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2395 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Expert Opinion on Pharmacotherapy is 26%.

Expert Opinion on Pharmacotherapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Opinion on Pharmacotherapy?

What is the APC / publication cost?

What is the acceptance rate?